All Blogs / Health / Diseases & Conditions / Cancer / New


Keeping A Cool Head On Cold Cap news

The Food and Drug Administration this week approved a device to reduce hair loss in women receiving chemotherapy for the treatment of breast cancer. The media attention has been extensive and highly favorable. But taking a closer look...Show More Summary

Making A Difference: The Melanoma Research Alliance

A full waiting room. To most of us, it’s a bad sign, as we anticipate the excruciatingly dull minutes ahead. But at a meeting I attended this past week, it was a sign of hope, of progress; of making a difference. I was in Washington...Show More Summary

Need To Balance Innovation, Benefits and Restraint When It Comes To The Rising The Costs Of Cancer Drugs

Cancer drugs—especially the new targeted and immunotherapies—are very, very expensive. No doubt about that, and there is also no lack of effort trying to cast blame on who bears responsibility for those costs. There is even a recent...Show More Summary

Change Happens: The Incredibly Rapid Pace of Change In Cancer Care

Change is a good thing, a necessary thing. At the same time, I have to ask how many realize how much change is happening so quickly in oncology and cancer care? And I wonder even more how we are going to separate change that is valuable...Show More Summary

Why Don’t We Pay As Much Attention To Prevention And Better Cancer Care As We Do To The Next Great New Cancer Drug?

The largest and most important cancer meeting of the year, the American Society of Clinical Oncology Annual Meeting, is going on this weekend in Chicago, and that’s a good time for one to give some thought to the broader topic of what...Show More Summary

Precision/Personalized Medicine: Can We Afford Our Success?

Here at the at annual meeting of the American Society of Clinical Oncology in Chicago, we are beginning to see the future of cancer therapy—and it raises a provocative question: will precision medicine become so precise, we risk turning...Show More Summary

Aromatase Inhibitors To Prevent Breast Cancer Recurrence: How Much Treatment Is Enough Treatment?

Here at the annual meeting of the American Society of Clinical Oncology in Chicago, we see results of eagerly awaited clinical trials that have involved hundreds or even thousands of patients, millions of dollars, and years of hard work and analysis. Show More Summary

We Are Beginning To Realize The Promise Of Cell Free DNA In Cancer Care

Right now, when we want to know everything we can about a tumor, we do surgery: a biopsy to take a sample of it and look at it under a microscope and determine as best we can how to treat it. But what if instead you could get a blood test, and learn even more. Show More Summary

The Cancer Moonshot Summit: A Day For Our Nation To Reflect And Commit To What We Can Accomplish To Make This Cancer’s Last Century

Cancer Moonshot Summit. Who would have imagined five short months ago that on this special day, almost 300 cancer centers and programs in every state attended by over 6000 leaders in cancer care and research, patients, advocates, and...Show More Summary

Sometimes Bold Predictions Do Come True: The Lesson Of Chronic Myeloid Leukemia

Perhaps more than most, doctors struggle with memories that mark sad moments in their careers. For me, one of the most indelible was about a wonderful young man with chronic myeloid leukemia (CML). When I started my oncology career in the early 1970’s, CML was almost always fatal. Show More Summary

Copyright © 2015 Regator, LLC